High number of seizures and unconsciousness in patients with SARS-CoV-2 omicron variants: a retrospective study

被引:0
|
作者
Tokuyama, Kishin [1 ]
Kitamura, Tsubasa [1 ]
Maruyama, Kazutaka [1 ,2 ]
Toriumi, Shun [1 ,2 ]
Murano, Yayoi [1 ,2 ]
Yoneoka, Daisuke [3 ]
Nakazawa, Tomoyuki [1 ,2 ]
Shimizu, Toshiaki [2 ]
机构
[1] Tokyo Metropolitan Toshima Hosp, Div Pediat, Tokyo, Japan
[2] Juntendo Univ, Fac Med, Dept Pediat, Tokyo, Japan
[3] Natl Ctr Infect Dis, Ctr Surveillance Immunizat & Epidemiol Res, Tokyo, Japan
来源
FRONTIERS IN PEDIATRICS | 2023年 / 11卷
关键词
COVID-19; SARS-CoV-2; omicron variants; febrile seizure; seizure; INFLUENZA; COVID-19;
D O I
10.3389/fped.2023.1273464
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variants are now a pandemic. There are differences in clinical features in SARS-CoV-2 variants and we conducted this study to assess the clinical features of coronavirus disease (COVID-19) in children with SARS-CoV-2 omicron variants. The study included children with COVID-19 arrivedto Tokyo Metropolitan Toshima Hospital between January 2020 and October 2022. The clinical features of 214 children with SARS-CoV-2 non-omicron variants and 557 children with omicron variants were compared. In the SARS-CoV-2 omicron variant group, more patients had fever, sore throat, nausea and/or vomiting, and seizures and/or disorders of consciousness. In SARS-CoV-2 non-omicron variants, there was only one patient with seizure and/or unconsciousness whereas there were 92 children in omicron variants. Among these 92 patients, 46 (49%) were diagnosed with simple febrile seizures; 23 (25%), with complex febrile seizures; 10 (11%) with status epilepticus; and two (2%) with encephalopathy. Their mean age was 4.0 +/- 3.0 years-a wider age distribution than that in other febrile seizures but similar to that in febrile seizures in patients with influenza. SARS-CoV-2 omicron variants are likely to cause seizures and unconsciousness in children and their age distribution was wider than other febrile seizures patients but similar to those in influenza patients. In clinical practice in patients with COVID-19 and influenza, clinicians should be aware of these features.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Characteristic analysis of Omicron-included SARS-CoV-2 variants of concern
    Yang, Hao
    Liu, Penghui
    Zhang, Yong
    Du, Tingfu
    Zhou, Yanan
    Lu, Shuaiyao
    Peng, Xiaozhong
    MEDCOMM, 2022, 3 (02):
  • [42] Insight into SARS-CoV-2 Omicron variants in Saudi Arabian genomic isolates
    Darwish, Doaa Bahaa E.
    SAUDI MEDICAL JOURNAL, 2022, 43 (11) : 1276 - 1279
  • [43] Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
    Liu, Wenhao
    Huang, Zehong
    Xiao, Jin
    Wu, Yangtao
    Xia, Ningshao
    Yuan, Quan
    VIRUSES-BASEL, 2024, 16 (02):
  • [44] Wavelength dependence of ultraviolet light inactivation for SARS-CoV-2 omicron variants
    Fujimoto, Nahoko
    Nagaoka, Katsuya
    Tatsuno, Ichiro
    Oishi, Hisashi
    Tomita, Makoto
    Hasegawa, Tadao
    Tanaka, Yasuhito
    Matsumoto, Takahiro
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Wavelength dependence of ultraviolet light inactivation for SARS-CoV-2 omicron variants
    Nahoko Fujimoto
    Katsuya Nagaoka
    Ichiro Tatsuno
    Hisashi Oishi
    Makoto Tomita
    Tadao Hasegawa
    Yasuhito Tanaka
    Takahiro Matsumoto
    Scientific Reports, 13
  • [46] Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England
    Oliver Eales
    Leonardo de Oliveira Martins
    Andrew J. Page
    Haowei Wang
    Barbara Bodinier
    David Tang
    David Haw
    Jakob Jonnerby
    Christina Atchison
    Deborah Ashby
    Wendy Barclay
    Graham Taylor
    Graham Cooke
    Helen Ward
    Ara Darzi
    Steven Riley
    Paul Elliott
    Christl A. Donnelly
    Marc Chadeau-Hyam
    Nature Communications, 13
  • [47] Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
    Cornish, Katy
    Huo, Jiandong
    Jones, Luke
    Sharma, Parul
    Thrush, Joseph W.
    Abdelkarim, Sahar
    Kipar, Anja
    Ramadurai, Siva
    Weckener, Miriam
    Mikolajek, Halina
    Liu, Sai
    Buckle, Imogen
    Bentley, Eleanor
    Kirby, Adam
    Han, Ximeng
    Laidlaw, Stephen M.
    Hill, Michelle
    Eyssen, Lauren
    Norman, Chelsea
    Le Bas, Audrey
    Clarke, John
    James, William
    Stewart, James P.
    Carroll, Miles
    Naismith, James H.
    Owens, Raymond J.
    OPEN BIOLOGY, 2024, 14 (06)
  • [48] Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
    Dong, Rui
    Hu, Taojun
    Zhang, Yunjun
    Li, Yang
    Zhou, Xiao-Hua
    VACCINES, 2022, 10 (04)
  • [49] Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
    Shiwa-Sudo, Nozomi
    Sakai, Yusuke
    Iwata-Yoshikawa, Naoko
    Watanabe, Shinji
    Yamada, Souichi
    Kuroda, Yudai
    Yamamoto, Tsukasa
    Shirakura, Masayuki
    Fujisaki, Seiichiro
    Miyazaki, Kaya
    Miura, Hideka
    Nagata, Shiho
    Fukushi, Shuetsu
    Maeda, Ken
    Hasegawa, Hideki
    Suzuki, Tadaki
    Nagata, Noriyo
    JOURNAL OF VIROLOGY, 2023, 97 (01)
  • [50] PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
    Su, Jingyi
    Zheng, Jing
    Huang, Wei
    Zhang, Yali
    Lv, Cairui
    Zhang, Baoding
    Jiang, Lina
    Cheng, Tong
    Yuan, Quan
    Xia, Ningshao
    Zhang, Jianming
    Li, Li
    Li, Li
    Deng, Xianming
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)